Virginia Economic Review

Medical Device Manufacturer Embody Sets Stage for International Growth For Norfolk-based Embody, Inc., the six-year process of product development, preclinical testing, and compliance hurdles to get its collagen-based tendon and ligament implant, Tapestry, into the U.S.

Partnership With JMU, BRCC Helps Merck Fill Need for HPV Vaccines In 2019, Melissa Lubin learned that pharmaceutical giant Merck & Co., Inc., was competing for a billion-dollar expansion in Elkton, a town in the Shenandoah Valley.

The highly transmissible omicron variant of the novel coronavirus upended perceptions about proper mitigation. People who had been wearing fabric masks began switching over to N95 and KN95 respirators, leading to greater demand for respirators.

During the COVID-19 pandemic, Virginia Tech's Rob Gourdie was busy investigating how to deliver medications more effectively.

Kimberly Kelly was a biomedical engineer at the University of Virginia (UVA), working on ways to diagnose pancreatic cancer, when she discovered a protein expressed by the cancer cells.

Universities, VA Bio+Tech Park Draw Investment to Richmond For communities seeking to recreate the success of well-known life sciences clusters in Boston, San Diego, and the San Francisco Bay Area, Genetic Engineering & Biotechnology News suggests there’s a straightforward formula to replicate.

Northern Virginia’s advantages in attracting talent are well known, from best-in-class public schools, to vibrant communities, to the attractions and sights of Washington, D.C.

Despite facing an unprecedented global pandemic, executives at GlaxoSmithKline Consumer Healthcare (GSK) were able to recruit 150 new employees for the company’s research and development center in Richmond.

Like many medical device startups, Luminoah began with a bright idea brought about by a personal need. In 2019, founder Neal Piper’s young son, Noah, had a medical issue that necessitated the use of a feeding tube.

Chandra Briggman is president and CEO of Activation Capital, an independent authority that supports life sciences and advanced technology companies and entrepreneurship in the Richmond area.

John Newby is CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in the Commonwealth.

Richmond and Petersburg Host a New Pharmaceutical Cluster Making Essential Medicines With Innovative Techniques The COVID-19 pandemic has brought shortages of all kinds to the U.S. economy, from cream cheese and toilet paper to N95 masks and consumer electronics.

Virginia Offers Best-in-Class Export Assistance for Companies' Complete Life Cycle Exporting can be a strong strategy for connecting companies with demand or diversifying their market bases to better weather economic conditions.

The last year has been challenging to all aspects of the logistics industry, and The Port of Virginia was not immune.

International trade is beneficial for American consumers and businesses alike. Benefits for consumers include lower costs and a greater variety of goods available in their local markets.

John Keppler is chairman, CEO, and co-founder of Enviva, the world's largest producer of woody biomass and one of Virginia's largest exporters out of its private terminal in the city of Chesapeake.

With Initial Funding Approved and Bold Goals on the Horizon, Virginia's International Trade Strategic Plan is Moving Forward The fundamental conditions are in place for Virginia to significantly grow its international trade. Now, the Commonwealth is setting a course to capitalize on those assets.

Stephen Edwards joined The Port of Virginia as CEO and executive director in January 2021. Before joining the port, he was president and CEO of TraPac, which operates container terminals in California and Florida.